(Q43775527)

English

High incidence of PTLD after non-T-cell-depleted allogeneic haematopoietic stem cell transplantation as a consequence of intensive immunosuppressive treatment.

scientific article published in July 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12815484%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

High incidence of PTLD after non-T-cell-depleted allogeneic haematopoietic stem cell transplantation as a consequence of intensive immunosuppressive treatment (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12815484%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12815484%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Petri S Mattila

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12815484%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12815484%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

author name string

Juvonen E

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12815484%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Aalto SM

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12815484%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Tarkkanen J

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12815484%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Knuutila S

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12815484%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Ruutu T

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12815484%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

language of work or name

0 references

publication date

1 July 2003

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12815484%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12815484%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

32

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12815484%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12815484%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

97-102

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12815484%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704089

0 references

Epstein-Barr virus infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704089

21 January 2018

Diagnosis and treatment of transplant-related lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704089

21 January 2018

Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704089

21 January 2018

Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell--depleted SCT.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704089

21 January 2018

Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704089

21 January 2018

Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704089

21 January 2018

CD-20 expression in post-transplant lymphoproliferative disorders: treatment with rituximab

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704089

21 January 2018

Chimaeric anti-CD20 monoclonal antibody (rituximab) in post-transplant B-lymphoproliferative disorder following stem cell transplantation in children.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704089

21 January 2018

Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704089

21 January 2018

Bone-marrow transplantation (second of two parts).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704089

21 January 2018

Lymphoproliferative disease after allogeneic stem cell transplantation--pre-emptive diagnosis by quantification of Epstein-Barr virus DNA in serum.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704089

21 January 2018

Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704089

21 January 2018

Lymphoproliferative disorders following allogeneic bone marrow transplantation: the Vancouver experience

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704089

7 January 2021

based on heuristic

inferred from DOI database lookup

bcl-2 protein is strongly expressed in post-transplant lymphoproliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704089

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704089

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1704089

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12815484%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12815484%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43775527&oldid=2103222706"